137234-92-5

Usage

Uses

Used in Pharmaceutical Industry:
2,4,5-TRIFLUORO-3-HYDROXYBENZOIC ACID METHYL ESTER is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties. Its unique structure allows for the creation of molecules with targeted actions, enhancing the effectiveness of medications.
Used in Agrochemical Industry:
In the agrochemical sector, 2,4,5-TRIFLUORO-3-HYDROXYBENZOIC ACID METHYL ESTER is used as a key component in the production of pesticides and other agrochemicals. Its incorporation aids in the development of compounds that can effectively control pests and diseases in agriculture, thus contributing to increased crop yields and protection of plants.
Used in Organic Compounds Synthesis:
2,4,5-TRIFLUORO-3-HYDROXYBENZOIC ACID METHYL ESTER is utilized as a building block in the synthesis of various organic compounds. Its reactivity and structural features make it a valuable precursor for creating a wide array of specialized chemicals used in different industries, including materials science and chemical research.

InChI:InChI=1/C8H5F3O3/c1-14-8(13)3-2-4(9)6(11)7(12)5(3)10/h2,12H,1H3

Upstream product

• 67-56-1 methanol 
• 116751-24-7 2,4,5-trifluoro-3-hydroxybenzoic acid 
• 79-37-8 oxalyl dichloride 
• 136897-64-8 methyl 3-methoxy-2,4,5-trifluorobenzoate 
• 616-38-6 carbonic acid dimethyl ester 
• 7486-35-3 tri-n-butyl(vinyl)tin 
• 147425-21-6 2,4,5-Trifluoro-3-trifluoromethanesulfonyloxy-benzoic acid methyl ester 
• 1042641-60-0 2,4,5-Trifluoro-3-hydroxy-benzoyl chloride 

Downstream Products

• 479090-82-9 3-tert-butoxycarbonylmethoxy-2,4,5-trifluorobenzoic acid methyl ester 
• 1093121-31-3 C₁₁H₇F₃N₂O₃S 
• 1093121-32-4 C₂₉H₂₅F₃N₂O₉S₂ 
• 1093121-00-6 C₂₈H₂₃F₃N₂O₉S₂ 
• 137234-93-6 3-trifluoromethyl sulfonyl-2,4,5-trifluoro methyl benzoate 
• 147425-21-6 2,4,5-Trifluoro-3-trifluoromethanesulfonyloxy-benzoic acid methyl ester 

Relevant academic research and scientific papers

1, 3 - DIHYDROXY SUBSTITUTED PHENYLAMIDE GLUCOKINASE ACTIVATORS

Compounds are provided which are glucokinase activators and thus are useful in treating diabetes and related diseases and have the structure wherein in the ring represents one or two double bonds; R1 is alkyl, aryl, arylalkyl, heteroaryl, or he

Antibacterial agents

The present invention provides compounds of formula (I): wherein R1-R6 and J and K have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antibacterial agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula I, processes for preparing compounds of formula I, and intermediates useful for preparing compounds of formula I.

Process for preparing alkyl 3-hydroxy-2, 4, 5-trifluorobenzoates and/or alkyl 3-alkoxy-2, 4, 5-trifluorobenzoates

The present invention relates to a process for preparing alkyl 3-hydroxy-2,4,5-trifluorobenzoate and/or alkyl 3-alkoxy-2,4,5-trifluorobenzoate by reacting 3-hydroxy-2,4,5-trifluorobenzoic acid with a dialkyl carbonate at 80° to 200° C.

3-Ethenyl, 3-Ethynyl, 3-Aryl, and 3-Cyclopropyl-2,4,5-Trifluorobenzoic Acids: Useful Intermediates In The Synthesis Of Quinolone Antibacterials

The synthesis of 3-ethenyl, 3-ethynyl, 3-aryl, and 3-cyclopropyl-2,4,5-trifluorobenzoic acids from 1-bromo-2,4,5-trifluorobenzene and 2,4,5-trifluoro-3-hydroxybenzoic acid is described.These compounds are useful intermediates for the synthesis of quinolon

Quinolinecarboxylic acid antibacterial agents

Novel 8-alkenyl, alkynyl, allenyl and cycloalkyl-quinolinecarboxylic acids are described as antibacterial agents as well as methods of manufacture including novel intermediates used in said manufacture.